Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qishao Tianxin Fang (芪芍天心方) is a traditional Chinese medicine (TCM) compound prescription. It is composed of multiple herbal ingredients, typically including Astragalus membranaceus (Huangqi), Paeonia lactiflora (Baishao), and other herbs, though the exact formulation may vary by source. This formula is used in TCM practice for its purported effects on promoting blood circulation, nourishing qi and yin, and calming the mind. The mechanism of action is based on TCM theory rather than modern pharmacology; it involves multi-target modulation such as anti-inflammatory effects, immune regulation, antioxidation, and improvement of microcirculation according to available studies on similar TCM compounds. Qishao Tianxin Fang has been investigated primarily for cardiovascular diseases such as hypertension or heart disease in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qishao Tianxin Fang.